Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Optimized treatment algorithm in early rheumatoid arthritis:
Methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the
treatment of early rheumatoid arthritis.
A Randomised, double-blind and placebo-controlled, two arms, parallel group study of the
additive effect of adalimumab concerning inflammatory control and inhibition of erosive
development.
Optimized Treatment Algorithms for Patients with Early RA
Phase:
Phase 3
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Aarhus University Hospital Abbott Meda Pharmaceuticals